Make your money go further for just 25p per day

PREMIUM
AIM IHT

Fever-Tree: still fizzing in the US

25/01/2024 · Aquis Exchange (AQX)  · Fevertree Drinks (FEVR)  · Keywords Studios (KWS)  · Team17 (TM17) 

AIM AIM Inheritance Tax potential UK

Fever-Tree cocktail mix

The premium mixer group is shaping up to be a rare UK success in the world’s largest market, but it’s journey has really only just begun; the Chairman clearly remains confident, acquiring a large number of shares. We were also impressed with progress from an unusual financial services group. Read on here for our thought on this and other news. (Premium)


Fever-Tree: fizzing in the US and margins on the rise

Fever-Tree: (AIM:FEVR), the creator of superlative premium mixers, reported decent progress in its trading update for the year to December 2023. With costs under better control, we can also look forward to significantly improved margins in 2024.

Group revenue rose 6% to c.£364m, marginally below consensus, with varying degrees of success in its geographical markets.

The US market was the standout performer, growing…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Aquis Exchange

Episode 3 of the Investor’s Champion Podcast

27/01/2024 · Podcasts

In this episode of the Investor’s Champion Podcast, Chris and Lee run through key news from…


Fever-Tree: still fizzing in the US

25/01/2024 · Company Insights

The premium mixer group is shaping up to be a rare UK success in the world’s…


More on Fevertree Drinks

Investor’s Champion Podcast Easter Special

30/03/2024 · Podcasts

This episode of the Investor's Champion Podcast discusses Donald Trump's latest stock market success, cocoa prices…


Bonkers Bargains are looking good

26/03/2024 · Company Insights

Results and updates covered here include impressive news from two of our Bonkers Bargain opportunities, one…


More on Keywords Studios

Episode 9 of the Investor’s Champion Podcast

16/03/2024 · Podcasts

This episode discusses Bitcoin's surging price, the UK competition authority's probe into the veterinary sector, Trainline's growth and…


AIM’s world leaders are poised

13/03/2024 · Company Insights

We pick through the latest results from two of AIM’s world leaders. The shares of both…


More on Team17

Fever-Tree: still fizzing in the US

25/01/2024 · Company Insights

The premium mixer group is shaping up to be a rare UK success in the world’s…


Ethically challenged | Doing nicely | Steady as ever

29/11/2023 · Company Insights

A company covered here has just reported stunning growth, yet its rating remains modest - unfortunately it’s…


More Company Insights

Bonkers Bargain: poised for recovery

16/04/2024 · Gattaca PLC

Takeover mania | Encouraging flows

Bonkers Bargain: update reassures and outlook maintained

11/04/2024

Sign-up to our free email updates

SIGN UP